A discussion with probiotic experts Dr. Allan Walker and Dr. Erika Isolauri
IXCHIQ chikungunya vaccine meets phase 2 endpoint in children
Already approved in those aged 18 and older in the United States, Valneva has submitted label extension applications to the FDA for IXCHIQ use in adolescents aged 12 to 17 years.
Food Insecurity and the Dangers of Infant Formula Dilution
AAP: These tips can keep kids comfortable amid cold & flu season
During the current cold and flu season, children have a higher risk of getting sick. The AAP has release tips and reminders for parents to help keep children comfortable and healthy.
Demystifying Infant Formula
ARS launches program to provide free neffy in eligible K-12 schools
Eligible schools have the opportunity to receive 2 cartons of epinephrine nasal spray for use in emergency situations to treat type I allergic reactions, including anaphylaxis.
Study: No association between montelukast and neuropsychiatric adverse event risk
"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.
